LeapFrog Enterprises Inc. Cl A (LF) Jumps 5.72% on December 30

Equities Staff |

LeapFrog Enterprises Inc. Cl A (LF) was among the biggest gainers on the Russell 2000 for Wednesday December 30 as the stock popped 5.72% to $0.72, representing a gain of $0.0389 per share. Some 530,133 shares traded hands on 988 trades, compared with an average daily volume of 565,376 shares out of a total float of 70.97 million. The stock opened at $0.66 and traded with an intraday range of $0.72 to $0.66.

After today's gains, LeapFrog Enterprises Inc. Cl A reached a market cap of $51.02 million. LeapFrog Enterprises Inc. Cl A has had a trading range between $4.85 and $0.61 over the last year, and it had a 50-day SMA of $0.75 and a 200-day SMA of $1.33.

Leapfrog Enterprises Inc designs, develops, and markets technology-based learning products and related proprietary content for children around the world.

LeapFrog Enterprises Inc. Cl A is based out of Emeryville, CA and has some 524 employees. Its CEO is John Barbour.

For a complete fundamental analysis analysis of LeapFrog Enterprises Inc. Cl A, check out Equities.com’s Stock Valuation Analysis report for LF. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…